Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor

References

• HeQGaoYZhangLA pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistanceBiomaterials201132307711772021816467
   PubMed Web of Science ®Google Scholar
• SimbergDDuzaTParkJHBiomimetic amplification of nanoparticle homing to tumorsProc Natl Acad Sci U S A2007104393293617215365
   PubMed Web of Science ®Google Scholar
• PearceTRShroffKKokkoliEPeptide targeted lipid nanoparticles for anticancer drug deliveryAdv Mater201224283803382222674563
   PubMed Web of Science ®Google Scholar
• ChangDKChiuCYKuoSYAntiangiogenic targeting liposomes increase therapeutic efficacy for solid tumorsJ Biol Chem200928419129051291619276080
   PubMed Web of Science ®Google Scholar
• GoskSMoosTGottsteinCBendasGVCAM-1 directed immunoliposomes selectively target tumor vasculature in vivoBiochim Biophys Acta20081778485486318211818
   PubMed Web of Science ®Google Scholar
• MannAPTanakaTSomasunderamALiuXGorensteinDGFerrariME-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrowAdv Mater20112336H278H28221833996
   PubMed Web of Science ®Google Scholar
• GuGGaoXHuQThe influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cellsBiomaterials201334215138514823582684
   PubMed Web of Science ®Google Scholar
• PeraboFSharmaSGiererRCirculating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignanciesIndian J Cancer20013811714758878
   PubMedGoogle Scholar
• ShiSYangKHongHTumor vasculature targeting and imaging in living mice with reduced graphene oxideBiomaterials201334123002300923374706
   PubMed Web of Science ®Google Scholar
• LiuDLiuFLiuZWangLZhangNTumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibodyMol Pharm2011862291230121923159
   PubMed Web of Science ®Google Scholar
• HuangSShaoKLiuYTumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangio-genesis and apoptosisACS Nano2013732860287123451830
   PubMed Web of Science ®Google Scholar
• ZhangYFWangJCBianDYZhangXZhangQTargeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studiesEuro J Pharm Biopharm2010743467473
   Web of Science ®Google Scholar
• XuanRLinLJiangDVascular targeting agent-combretastatin A4Chinese Journal of New Drugs2007161713361341 Chinese
   Google Scholar
• YangTWangYLiZTargeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculatureNanomedicine201281819221664295
   PubMed Web of Science ®Google Scholar
• NelkinBDBallDWCombretastatin A-4 and doxorubicin combination treatment is effective in a preclinical model of human medullary thyroid carcinomaOncol Rep20018115716011115589
   PubMed Web of Science ®Google Scholar
• MitrusISochanikACichońTSzalaSCombination of combretastatin A4 phosphate and doxorubicin-containing liposomes affects growth of B16-F10 tumorsActa Biochim Pol200956116116519287800
   PubMed Web of Science ®Google Scholar
• ZhangFHuangXZhuLNoninvasive monitoring of orthoto-pic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticlesBiomaterials201233215414542222560667
   PubMed Web of Science ®Google Scholar
• ShenoiMMIltisIChoiJNanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nano-particles for multimodal cancer therapyMol Pharm20131051683169423544801
   PubMedGoogle Scholar
• ChenYChenHZengDCore/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug deliveryACS Nano20104106001601320815402
   PubMed Web of Science ®Google Scholar
• HauckTSGhazaniAAChanWCAssessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cellsSmall20084115315918081130
   PubMed Web of Science ®Google Scholar
• LeboldTJungCMichaelisJBräuchleCNanostructured silica materials as drug-delivery systems for doxorubicin: single molecule and cellular studiesNano Lett2009982877288319572735
   PubMed Web of Science ®Google Scholar
• HeQGaoYZhangLOne-pot self-assembly of mesoporous silica nanoparticle-based pH-responsive anti-cancer nano drug delivery systemJ Mater Chem201121391519015192
   Web of Science ®Google Scholar
• HeQShiJMSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibitionAdv Mater201426339141124142549
   PubMed Web of Science ®Google Scholar
• ChenYChenHShiJIn vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticlesAdv Mater201325233144317623681931
   PubMed Web of Science ®Google Scholar
• SugaharaKNTeesaluTKarmaliPPTissue-penetrating delivery of compounds and nanoparticles into tumorsCancer Cell200916651052019962669
   PubMed Web of Science ®Google Scholar
• MaMChenHChenYAu capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemotherapy and multimodal imagingBiomaterials201233398999822027594
   PubMed Web of Science ®Google Scholar
• HeQZhangJChenFGuoLZhuZShiJAn anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mes-oporous silica nanoparticlesBiomaterials201031307785779620674009
   PubMed Web of Science ®Google Scholar
• GaoYYangCLiuXMaRKongDShiLA multifunctional nanocarrier based on nanogated mesoporous silica for enhanced tumor-specific uptake and intracellular deliveryMacromol Biosci201212225125922076739
   PubMed Web of Science ®Google Scholar
• HeQShiJMesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibilityJ Mater Chem2011211658455855
   Web of Science ®Google Scholar